AHMED MUMTAZ 4
4 · GENELABS TECHNOLOGIES INC /CA · Filed Jan 26, 2004
Insider Transaction Report
Form 4
AHMED MUMTAZ
V.P.Drug Development
Transactions
- Award
Incentive Stock Option
2004-01-23+30,000→ 30,000 totalExercise: $2.50Exp: 2014-01-23→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]These Options become exercisable 25% one year from grant date and the remainder pro rata monthly over the next three years.
- [F2]Per share exercise price of option grant.